Antiseptic Skin Preparation for Joint Replacement Surgery
(CLEANJoint Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to compare two types of skin preparation solutions (chlorhexidine gluconate-alcohol solution and povidone-iodine solution) that help eliminate harmful bacteria on the skin at the time of surgery for patients having revision arthroplasty surgery of the hip or knee. The main outcome of interest for the definitive study is the need for re-operation for a wound complication or an infection of the prosthetic joint within one year after surgery. For the pilot trial, our main interest is to determine feasibility of a definitive trial. Feasibility outcomes will include: ability to recruit patients, ability to randomize patients, ability to collect complete data, estimate the event rate of our primary outcome, ability to carry out data linkages and determine the accuracy of collected data. Participants will be contacted at two time points after surgery to complete a 5-minute survey: after 30 days, and after 1 year.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on skin preparation solutions for surgery.
What data supports the effectiveness of the treatment Chlorhexidine Gluconate-Alcohol Solution and Povidone-Iodine Solution for antiseptic skin preparation in joint replacement surgery?
Research shows that antiseptic solutions containing chlorhexidine gluconate and povidone iodine, especially when combined with alcohol, are effective in reducing the risk of surgical site infections by killing bacteria on the skin before surgery. These solutions are commonly used in various surgeries, including cardiac and abdominal, to prevent infections.12345
Is antiseptic skin preparation safe for humans?
How does the antiseptic skin preparation treatment for joint replacement surgery differ from other treatments?
Research Team
Raman Mundi, MD MSc FRCSC
Principal Investigator
Sunnybrook Health Sciences Centre
Eligibility Criteria
This trial is for adults aged 18 or older who are scheduled to have revision surgery on a hip or knee replacement where at least one artificial joint part will be swapped out. It's not suitable for those with conditions that might interfere with the study.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo revision arthroplasty surgery with either chlorhexidine gluconate-alcohol solution or povidone-iodine solution for skin preparation
Follow-up
Participants are monitored for re-operation, wound complications, and infection of the prosthetic joint. Surveys are conducted at 30 days and 1 year post-surgery.
Treatment Details
Interventions
- Chlorhexidine Gluconate-Alcohol Solution
- Povidone-Iodine Solution
Chlorhexidine Gluconate-Alcohol Solution is already approved in European Union, United States, Canada, Switzerland for the following indications:
- Surgical skin preparation
- Prevention of surgical site infections
- Surgical skin preparation
- Prevention of surgical site infections
- Surgical skin preparation
- Prevention of surgical site infections
- Surgical skin preparation
- Prevention of surgical site infections
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sunnybrook Health Sciences Centre
Lead Sponsor